Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-18

Clinical Trial Update: The Antibacterial Effect of Nanosilver Fluoride on Primary Teeth [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the antibacterial effect of nanosilver fluoride on primary teeth was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nanosilver Fluoride (nanosilver fluoride)

Snippet

Sponsor: Nour Ammar, BDS | Conditions: Primary Teeth, Microbial Colonization | Phase 3 | Status: TERMINATED | Results posted: 2023-08-18